Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$57.92 - $72.58 $206,774 - $259,110
-3,570 Closed
0 $0
Q2 2021

Aug 26, 2021

BUY
$63.47 - $69.35 $11,741 - $12,829
185 Added 5.47%
3,570 $246,000
Q1 2021

May 13, 2021

BUY
$60.0 - $68.46 $203,100 - $231,737
3,385 New
3,385 $219,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Penn Mutual Asset Management, LLC Portfolio

Follow Penn Mutual Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Mutual Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penn Mutual Asset Management, LLC with notifications on news.